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Objectives. The aim of this study is to compare the endothelial integrity of saphenous vein grafts harvested by minimally
invasive surgery and veins harvested conventionally for coronary artery bypass surgery in 200 participants who were
assigned to interventions by using random allocation.
Design. Randomized controlled trial.
Methods. Immunocytochemistry with anti-CD 31 antibodies and anti-nitric oxide synthase (NOS) antibodies were
employed to identify the endothelial integrity.
Results. The CD 31 immunostaining showed that the endothelial cell integrity of the minimally invasive harvested veins
was preserved in 82 ^ 13% of the circumference of luminal endothelium, while in conventionally harvested grafts it was
reduced to 64 ^ 15% (p ¼ 0.05).> This was associated with the lack of CD 31 expression in vasa vasorum (10 and 18%) in
both groups, respectively, (p ¼ 0.02). The NOS immunostaining revealed that the endothelial integrity of the minimally
invasive harvested grafts was preserved in 96 ^ 4% of the luminal endothelium circumference as compared to 74 ^ 10% in
conventionally harvested grafts (p ¼ 0.05). The percentage of cases with the lack of NOS expression in all vasa vasorum was
12 and 21%, in G1 and G2, respectively, (p ¼ 0.02).
Conclusion. The endothelial integrity of saphenous vein grafts harvested by minimally invasive surgery is better preserved
than with the grafts obtained by the conventional manner. This could play an important role in improving vein graft patency
rates.
Key Words: Saphenous vein harvesting; Minimally invasive surgery; Endothelial integrity; CD 31 antigen; Nitric oxide
synthase.
Introduction
The autologous saphenous vein is the most commonly
used conduit for coronary artery bypass surgery
(CABG).1,2 Occlusion rates for saphenous vein grafts
used in CABG are relatively high: up to 15–30%
during the first year and approximately 50% within 10
years.3,4
The simplest method of saphenous vein harvesting
includes a continuous skin incision over the entire
length of the vein. In this conventional technique, the
perivascular tissue is stripped from the vein and
venospasm observed during vein harvest is overcome
by vein distention. This may result in the significant
denudation of the endothelium.5 Recently, less inva-
sive approaches have been reported in order to
minimize surgical trauma and decrease the number
of postoperative complications.6 – 9 One of them
includes saphenous vein harvesting with the use of
vascular Mayo strippers.6 The rationale for this
technique is that it provides a cushion of surrounding
tissue and reduces venospasm, so that it eliminates the
need of distention.
CD 31, expressed on all continuous endothelia, is a
single chain type-1 transmembrane protein belonging
to the immunoglobulin superfamily.10 Nitric oxide,
which mediates vasodilatation and plays an important
role in the maintenance of vascular tone, is syn-
thesized from L-arginine in the vascular endothelium
by the endothelial nitric oxide synthase (eNOS).11
Endothelial injury results in impaired nitric oxide
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release by endothelial cells.12 Thus, the preservation of
endothelial integrity in vein grafts may improve graft
patency rates by preserving nitric oxide activity.13
The aim of this study was to compare, both
histologically and immunocytochemically, the endo-
thelial integrity of saphenous vein grafts harvested by
minimally invasive surgery with the use of vascular
Mayo strippers to those obtained by the conventional
technique in a randomized controlled trial.
Patients and Methods
The study group comprised 200 patients whose
autogenous saphenous veins were used for CABG in
the Department of Cardiac Surgery, University of
Medical Sciences in Poznan´, Poland, between 2000 and
2002. All patients who were between 45 and 70 years of
age were candidates for inclusion in the study. They
were not admitted to the study if any of the following
criteria were present: (1) age.70 year, (2) body weight
.95 kg, or (3) the need of bilateral vein harvesting.
Patients were simply randomized, according to a
random coin-throw, to harvest a saphenous vein either
by means of the Mayo technique (group 1) or the
conventional technique (group 2). An adequate allo-
cation concealment was performed to protect the
sequence after allocation. Local ethics committee
approval and informed consent from patients was
obtained.
In group 1 (G1, n ¼ 100) the skin was incised over a
length of 1–2 cm at the site of branches traced during
USG-Doppler examinations. The vein between skin
incisions was dissected free with the use of vascular
Mayo strippers. When the distal end of the vein was
ligated, it was cut and introduced into the stripper’s
eye. Vascular stripper movements along the vein’s
course caused dissection of adjacent soft tissues. The
mean time taken to harvest the saphenous vein in this
method was 63 ^ 16 min. The mean length of har-
vested graft was 34 ^ 9 cm.
In group 2 (G2, n ¼ 100) the conventional technique
was employed. The mean time taken to harvest a vein
for CABG using this technique was significantly
longer (77 ^ 19 min, p , 0:05). The mean length of a
vein graft, as compared to G1, did not differ
significantly (35 ^ 7 cm). Also, patient age, height,
weight and rate of diseases potentially influencing
wound healing did not differ between groups
(Table 1).
The distal part of harvested veins (about 1 cm long)
were taken with their surrounding tissue for immu-
nohistochemical analysis just prior to grafting. All
tissue samples were fixed in a 10% formalin solution,
embedded in paraffin and cut into 5–6 mm thin
sections.
CD 31 antigen and eNOS detection involved the use
of the immunocytochemical procedure with mouse
monoclonal antibodies against human CD 31 (Dako, M
0823) and against human endothelial eNOS (Sigma, N
9532) consequently, followed by the StreptABCom-
plex/HRP method modified by biotinylated tyramine
(Dako Catalysed Signal Amplification System, Peroxi-
dase, K 1500).14 – 16 The endogenous activity of
peroxidase was blocked by a 10 min pre-incubation
in 10% hydrogen peroxide. The sections were incu-
bated with anti-CD 31 antibodies diluted 1:500–1:1000
and anti-eNOS antibodies diluted 1:3000 for 18 h at
þ4 8C. Incubation with the second antibody (biotiny-
lated goat anti-mouse, Dako E 0433, diluted 1:300) was
performed in room temperature for 60 min. This was
followed by incubation with diaminobenzidine (Dako
S 3000). Both analyses were performed blind on coded
samples and complied with the principles of positive
and negative controls.17
Quantitative assessment of CD 31 stainings of
saphenous vein sections were carried out using
Olympus MicroImage imaging software. This was
performed on vessels from all 200 patients. The
amount of positive luminal immunostaining was
measured with a Polaroid CCD camera attached to a
Nikon Eclipse E 600 microscope at £ 4 magnification.
The perimeter of the lumen was measured and
endothelial integrity, defined by CD 31 and eNOS
stainings, was expressed as a percentage of the lumen
length (Table 2).
Table 1. Preoperative patient data
G1 ðn ¼ 100Þ G2 ðn ¼ 100Þ
Age (year) 57 (48–67) 61 (52–68)
Gender (male/female) 93/7 90/10
Height (cm) 173 (165–179) 172 (164–179)
Weight (kg) 79 (74–92) 77 (68–91)
Length of vein graft (cm) 35 (26–43) 35 (28–41)
Time of vein harvesting (min) 62 (47–80) 75 (58–96)
Diabetes mellitus (number of cases) 14 (14%) 13 (13%)
Obliterative atheromatosis (number of cases) 10 (10%) 12 (12%)
Endothelial Integrity 245
Eur J Vasc Endovasc Surg Vol 27, March 2004
To have an 85% chance of detecting a significant
difference in endothelial integrity between the two
groups, with an assumed standard deviation of 20.0,
100 patients (200 in total) in each group were required.
The results were reviewed every six months to
enable the study to be terminated early if clear results
emerged. According to this, three interim analyses
were performed during the trial. The results, however,
were not statistically significant until the final analysis.
Data analysis was performed by means of paired
and unpaired t-student and chi-squared tests with
continuous Yates’ correction. P , 0:05 was considered
as statistically significant.
Results
Diagrammatic representation of the sample size is presented
in Fig. 1
The CD 31 immunostaining showed that the endo-
thelial cell integrity of the minimally invasive har-
vested veins was preserved in 82 ^ 13% of the luminal
endothelium circumference, while in conventionally
harvested grafts it was reduced to 64 ^ 14% ðp ¼ 0:05Þ:
In the former, (Fig. 2(a)), positive CD 31 immunostain-
ing was often evident as folds within the vessel lumen,
whereas staining in traditionally obtained vessels (Fig.
2(b)) was patchy and less folded due to the saline
distension. In the minimally invasive harvested grafts,
immunostaining was also present in some vasa
vasorum (Fig. 2(c) and (d)). The percentage of cases
with the lack of CD 31 expression in vasa vasorum was
10 and 18%, in G1 and G2, respectively, ðp ¼ 0:02Þ:
NOS was identified both in the luminal and
microvascular endothelium. In G1, the presence of
NOS was almost continuous with the perimeter of the
lumen in all vessels harvested by means of the
minimally invasive technique (Fig. 2(e)) while in
the traditionally harvested grafts it was reduced
(Fig. 2(f)). This immunostaining showed that the
endothelial integrity of the minimally invasive har-
vested grafts was preserved in 96 ^ 4% of the
circumference of the luminal endothelium as com-
pared to 74 ^ 10% in the conventionally harvested
grafts ðp ¼ 0:05Þ: The expression of NOS in vasa
vasorum was present in perivascular tissues (G1)
(Fig. 2(g)) and in the media (G1 and G2) (Fig. 2(h)) of
Fig. 1. Diagrammatic representation of samle size.
Table 2. Endothelial integrity of saphenous vein graft sections
G1 G2 Statistical significance
Luminal CD 31 staining (% of the total circumference ^ SD) 82 ^ 13 64 ^ 14 p ¼ 0:05
Lack of CD 31 expression in vasa vasorum (% of cases) 10 (10%) 18 (18%) p ¼ 0:02
Median luminal NOS staining (% of the total circumference ^ SD) 96 ^ 4 74 ^ 10 p ¼ 0:05
Lack of NOS expression in vasa vasorum (% of cases) 12 (12%) 21 (21%) p ¼ 0:02
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saphenous grafts. The percentage of cases with a lack
of NOS expression in all vasa vasorum was 12 and
21%, in G1 and G2, respectively, ðp ¼ 0:02Þ:
No marked surgical complications were observed
in G1 during the postoperative period. In G2, one
patient required revision due to wound bleeding, and
in four cases wound infection followed by delayed
healing were noted.
Discussion
Damage to the venous wall as a consequence of
incautious dissecting is a significant factor influencing
the patency of aorto-coronary grafts during the long-
term follow-up.3,4,18 It facilitates thrombus formation
within its lumen, and eventually may lead to occlusion
of a part of venous grafts even one year after the
operation.19,20 Results of post-mortem examinations
conducted by other authors demonstrate that even
more that 70% of occluded graft cases are preceded by
parietal thrombi covering the damaged endothelial
surface.21 On the other hand, one of the major factors
associated with vein graft failure is thought to result
from the adaptation of the vein to arterial conditions
(increased pressure, pulsative motion). The recon-
struction of the venous wall can take place if the
endothelial integrity is well preserved. Nitric oxide
plays an important role by influencing vascular
smooth muscle cell proliferation and migration.
Removal of the adventitia, which usually occurs in
conventional vein harvesting, reduces the tissue mass
of the graft vein, making it more prone to distention,
endothelial damage and subsequent graft failure.22
There is also evidence to show that adventitial injury is
involved in vessel occlusion, via activation of adven-
titial fibroblasts23 and local tissue ischaemia as a result
of damage to adventitial microvessels.24 Preservation
of the adventitia has been suggested to improve vein
graft patency.25
The introduction of the new minimally invasive
technique for vein harvesting could result in more
expressed saphenous vein damage than when using
the conventional technique. The first prospective
study to assess the functional quality of a saphenous
vein harvested with the use of a vascular Mayo
stripper was undertaken between 1979 and 1984.6
Both light electron microscopy and scanning electron
microscopy demonstrated that the harvested vein was
of good quality and that the intima had been well
preserved. Postoperative graft angiography and exer-
cise testing confirmed high patency rates for the vein
graft (93%). This method, however, has not been
universally accepted because of a perceived increase in
injury to the venous conduit. For this reason, in 1997
and 1998 studies were assessed to check the vascular
reactivity and endothelial integrity of veins harvested
with the use of Mayo stripper.26,27 To compare
contractile function, a saphenous vein was harvested
both by Mayo stripper and in the traditional ‘open’
technique in the same patient. The study revealed that
there was no significant difference in response to both
constrictors and dilators, in a medium containing 5-
hydroxytryptamine or noradrenaline, between vein
grafts taken using both methods.26 The endothelial
release of vasoactive substances after endoscopic
harvesting was also similar to that after the traditional,
extended incision technique.27 Histological examin-
ation by light and electron microscopy was unable to
show any significant damage to the vessel wall.26,27
However, these studies enrolled relatively small
numbers of patients and employed varied designs.
In our study, the endothelial integrity of saphenous
vein grafts was assessed by means of the endothelium-
specific antibody anti-CD 31 and anti-eNOS.10,22
Before this analysis was performed, the authors
expected that endothelial integrity in minimally
invasive harvested grafts would not be worse than
that in traditionally obtained veins. The presented
randomized controlled trial has revealed that endo-
thelial integrity is even better preserved than that in
conventionally harvested grafts. This integrity could
also be observed in vasa vasorum.
Although the CD 31 antigen is a useful marker for
Fig. 2. (a) The CD 31 immunostaining of luminal endothelium (arrows) of saphenous vein graft harvested by means of
minimally invasive surgery. It is evident as folds within the vessel lumen £ 100. (b) The CD 31 immunostaining of luminal
endothelium (arrows) of saphenous vein graft obtained in traditional manner. The staining is patchy and less folded due to
the saline distention £ 100. (c) The CD 31 immunopositive microvascular endothelium (arrows) in media of saphenous vein
section presented on Fig. 1. Luminal endothelium with positive expression of CD 31 (stars) is also seen £ 250. (d)
Immunocytochemical staining of CD 31 in vasa vasorum (arrows) of saphenous vein graft from G2 group £ 250. (e) The
immunocytochemical presence of NOS in the luminal epithelium of saphenous vein graft harvested by means of minimally
invasive surgery (stars). The expression od NOS is also present in microvascular endothelium of media and adventitia
(arrows) £ 100. (f) Extremely reduced NOS immunostaining of luminal endothelium of saphenous vein graft obtained in
traditional manner £ 100. (g) The immunocytochemical expression of NOS in microvascular endothelium in media (arrows)
of saphenous vein graft from G1 £ 250. (h) The immunocytochemical expression of NOS in microvascular endothelium in
media (arrows) of saphenous vein graft from G2 £ 250.
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the presence or absence of endothelium, its presence
does not exclude the possibility that intimal hyper-
plasia may develop—the pathologic lesion responsible
for the majority of early vein graft failures.28
On the other hand, the results of NOS immuno-
detection suggest that the enzyme expression is also
better preserved on the luminal endothelium of
grafts harvested by the minimally invasive method
as compared to the traditional technique. Apart
from being located on the luminal endothelium,
NOS was also expressed in the microvascular
endothelium within the media (G1 and G2) and
adventitia (G1), which may result in a better
supplementation of NO to the media. Vessels
harvested by means of minimally invasive surgery
might maintain their NO-producing capacity in vivo,
which could reduce the incidence of vessel occlu-
sion by promoting vasodilatation and reducing
platelet aggregation and thrombus formation.22
The available literature repeatedly signifies that
different minimally invasive surgery techniques
limit surgical complications and postoperative
pain.1,9,29 Only individual reports demonstrate that
minimally invasive techniques enable improved
preservation of the endothelial integrity in lumen
of harvested grafts and in vasa vasorum with the
use of the immunocytochemical technique22 and
electron microscopy study.30 These methods also
result in a lower occlusion rate in a prospective
study of coronary artery bypass surgery.22
Despite the size and duration of this trial, it is
important for clinicians to be able to estimate the
occlusion rate for saphenous vein grafts harvested by
the Mayo technique. Therefore, the observation of the
study group (up to 10 years) must be fully completed.
Consequently, the results of this study do not address
the occlusion rate in saphenous vein grafts. Moreover,
the present results, for patients who did not meet
eligible criteria, cannot be simply extrapolated to all
patients seen in general clinical practice.
Conclusion
The endothelial integrity of saphenous vein grafts
harvested by minimally invasive surgery is better
preserved as compared to grafts obtained by the
conventional manner. The preservation of endo-
thelium in minimally invasive techniques could play
an important role in improving long term vein graft
patency rates of vein grafts.
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